A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Clinical trial NCT06682806 · TERMINATED

Trial details

NCT number: NCT06682806
Sponsor: Prelude Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Esophageal Cancer Metastatic Solid Tumor Non-small Cell Lung Cancers SMARCA4 Gene Mutation

Start date: 2025-06-03
Primary completion: 2026-01-23
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.